OTC · Biotechnology

Allena Pharmaceuticals, Inc. (ALNAQ) Stock

$0.00 OTC: ALNAQ Healthcare

Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies.

Valuation

MetricValue
Price$0.00
Market Cap$122
P/E Ratio—
P/B Ratio0.00
P/S Ratio—
EPS (TTM)$-0.73
52-Week High$6.00
52-Week Low—
Dividend Yield—

Financials & Margins

MetricValue
ROE-263.16%
ROA-142.86%
ROCE-252.63%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity0.53
Current Ratio2.06

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$0$0$0$0
Operating Profit$-21.0M$-36.0M$-46.0M$-32.0M$-48.0M
Net Profit$-22.0M$-36.0M$-48.0M$-33.0M$-50.0M
EPS$-1.05$-1.72$-2.15$-1.01$-0.73
Op Margin—————

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$96.0M$65.0M$34.0M$39.0M$35.0M
Total Liabilities$13.0M$16.0M$17.0M$16.0M$16.0M
Cash$94.0M$62.0M$30.0M$35.0M$30.0M
Borrowings$9.0M$10.0M$10.0M$11.0M$10.0M

Latest News

South Korea says the chance of 3% economic growth has risen sharply Reuters · Aug 6, 2026 Walmart's bestselling 5-tier adjustable shelf that holds up to 750 pounds is on sale for $34 TheStreet · Aug 6, 2026 Dow Jones Futures: Nvidia Lifts Dow, But Google, SpaceX Skid; Sandisk, Western Digital Lead Earnings Losers Late Investor's Business Daily · Aug 6, 2026 BAM (BAM) Q2 2026 Earnings Call Transcript Motley Fool · Aug 6, 2026 Mike Lindell steps down as MyPillow CEO to focus on Minnesota campaign USA TODAY · Aug 6, 2026

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$-21.0M$-32.0M$-44.0M$-28.0M$-46.0M
Investing Cash Flow$23.0M$-1.0M$0$-1.0M$-1.0M
Financing Cash Flow$67.0M$9.0M$12.0M$34.0M$41.0M
Net Cash Flow$69.0M$-33.0M$-32.0M$5.0M$-5.0M
Free Cash Flow$-21.0M$-32.0M$-44.0M$-29.0M$-46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-37704918.03%
Quick Ratio2.06
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Allena Pharmaceuticals, Inc.

Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Allena Pharmaceuticals, Inc. (ALNAQ) stock trades at $0.00 with a market capitalization of $122. The stock is valued at price-to-book of 0.00.

On profitability, Allena Pharmaceuticals, Inc. generates a return on equity (ROE) of -263.16%, return on capital employed of -252.63%.

Official website: www.allenapharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides